MapLight Therapeutics, Inc. MPLT Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by MapLight Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about MapLight Therapeutics, Inc. 's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MapLight Therapeutics, Inc. 's total operating expenses?
- MapLight Therapeutics, Inc. (MPLT) reported total operating expenses of $64.5M in Q1 2026.
- How has MapLight Therapeutics, Inc. 's total operating expenses changed year-over-year?
- MapLight Therapeutics, Inc. 's total operating expenses increased by 174.0% year-over-year, from $23.54M to $64.5M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.